201 filings
Page 2 of 11
8-K
ha715pz1pu6wrtsk
17 Jul 23
Material Modifications to Rights of Security Holders
4:05pm
8-K
99wkhrh h9m1jbxdw01
10 Jul 23
Entry into a Material Definitive Agreement
5:16pm
8-K
7atdh8
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
ufvjh3 9pzc02pg8jdz
16 Jun 23
Evofem Biosciences Announces Financial Results for the First Quarter of 2023
4:01pm
8-K
yzau0tcre9okum 78
1 Jun 23
Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
8:36am
8-K
kl5m 7sklxx
17 May 23
Evofem Biosciences Announces 1-for-125 Reverse Stock Split
5:13pm
8-K
eu0q5li3ejkb
5 May 23
Other Events
5:00pm
8-K
c4g6y8t44g
28 Apr 23
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update
6:50am
8-K
685wh 67md3
14 Apr 23
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary
9:05am
8-K/A
akz694w2 98x
11 Apr 23
Entry into a Material Definitive Agreement
8:17pm
8-K
2nf4q
10 Apr 23
Entry into a Material Definitive Agreement
5:26pm
8-K
f5tiye70o
24 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
p7i37d09pm 9nt4i
20 Mar 23
Evofem Biosciences Announces Cost Reduction Measures
9:55pm
8-K
p9joh96t4e09w 6jzg6u
16 Mar 23
Submission of Matters to a Vote of Security Holders
7:07pm
8-K
6xl3pmn008zsbh
14 Mar 23
Entry into a Material Definitive Agreement
9:00am
8-K
gtx5k30ytpou
10 Mar 23
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:27pm
8-K
wubmd 9agw7
9 Mar 23
Evofem Biosciences Appoints Interim Chief Financial Officer
4:01pm
8-K
fw79 j6fom07vq
23 Feb 23
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value
8:59pm
8-K
b5jiaouj0
23 Feb 23
Entry into a Material Definitive Agreement
3:29pm
8-K
69uvcncx
16 Feb 23
Departure of Directors or Certain Officers
4:49pm